According to the outcomes, PCT level of patients with lung cancer with PD (PD-chemotherapy) was higher than that of patients with non-PD-chemotherapy (the response to chemotherapy was SD and PR) in bacteria-infected subgroup B (p = 0.0057) (Figure 4(b)). This evidence concerns the gene CALCA and lung cancer.